» Articles » PMID: 39894823

Serotonin Attenuates Tumor Necrosis Factor-induced Intestinal Inflammation by Interacting with Human Mucosal Tissue

Overview
Journal Exp Mol Med
Date 2025 Feb 2
PMID 39894823
Authors
Affiliations
Soon will be listed here.
Abstract

The intestine hosts the largest immune system and peripheral nervous system in the human body. The gut‒brain axis orchestrates communication between the central and enteric nervous systems, playing a pivotal role in regulating overall body function and intestinal homeostasis. Here, using a human three-dimensional in vitro culture model, we investigated the effects of serotonin, a neuromodulator produced in the gut, on immune cell and intestinal tissue interactions. Serotonin attenuated the tumor necrosis factor-induced proinflammatory response, mostly by affecting the expression of chemokines. Serotonin affected the phenotype and distribution of tissue-migrating monocytes, without direct contact with the cells, by remodeling the intestinal tissue. Collectively, our results show that serotonin plays a crucial role in communication among gut-brain axis components and regulates monocyte migration and plasticity, thereby contributing to gut homeostasis and the progression of inflammation. In vivo studies focused on the role of neuromodulators in gut inflammation have shown controversial results, highlighting the importance of human experimental models. Moreover, our results emphasize the importance of human health research in human cell-based models and suggest that the serotonin signaling pathway is a new therapeutic target for inflammatory bowel disease.

References
1.
Jacobson A, Yang D, Vella M, Chiu I . The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes. Mucosal Immunol. 2021; 14(3):555-565. PMC: 8075967. DOI: 10.1038/s41385-020-00368-1. View

2.
Serio R, Zizzo M . The multiple roles of dopamine receptor activation in the modulation of gastrointestinal motility and mucosal function. Auton Neurosci. 2022; 244:103041. DOI: 10.1016/j.autneu.2022.103041. View

3.
Martin C, Osadchiy V, Kalani A, Mayer E . The Brain-Gut-Microbiome Axis. Cell Mol Gastroenterol Hepatol. 2018; 6(2):133-148. PMC: 6047317. DOI: 10.1016/j.jcmgh.2018.04.003. View

4.
Eisenhofer G, Aneman A, Friberg P, Hooper D, Fandriks L, Lonroth H . Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab. 1997; 82(11):3864-71. DOI: 10.1210/jcem.82.11.4339. View

5.
Xue R, Zhang H, Pan J, Du Z, Zhou W, Zhang Z . Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis. Front Immunol. 2018; 9:2398. PMC: 6199378. DOI: 10.3389/fimmu.2018.02398. View